Patient Fluid Status Monitor Device Market Size, Share, Industry, Forecast and outlook (2024-2031)

Patient Fluid Status Monitor Device Market is Segmented By Type (Non-invasive, Invasive), By Indication(Kidney disease, Dehydration, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Report Overview

Global Fluid Status Monitor Device Market is estimated at a CAGR of 8.32% during the forecast period (2024-2031).

A patient fluid status monitor device is a device that measures hydration in a patient and determines if the patient is dehydrated or retaining fluids in a clinical setting. Clinicians can optimize treatment regimens and hydration in heart failure patients by assessing fluid volume status; patient fluid status monitor devices are also employed to treat hypertension and ESRD patients.

Patient Fluid-Status monitor Device Market Summary

For know more Insights - Download Sample

Market Dynamics

Innovations in the medical devices by the market players to diagnose the fluid content in the body are expected to drive in the forecast period.

Sensible Medical Innovations, an Israel-based company, has developed a new standard of care in lung fluid management. Sensible developed the ReDS medical radar technology from defence see-through wall application. The technology is well-positioned to be a game-changer in a wide range of applications and become the next-generation monitoring and imaging modality. Moreover, Sensible Medical Innovations' non-invasive thoracic fluid status monitor gained FDA 510(k) clearance. The Sensible product is designed to track and manage patients with fluid management issues, such as those with heart failure, those on diuretics, and those recuperating from a coronary artery disease-related incident. It is intended for use in hospitals, hospital-like facilities, and home situations by skilled health care practitioners and patients under the supervision of a physician. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

High cost of the equipment, lack of qualified specialists, errors in the machine during the process are some of the factors the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. Severe COVID-19 is frequently characterized by multiorgan failure, including hypotension and shock, acute respiratory failure, acute kidney injury, coagulation abnormalities, and others. Both bacterial sepsis and COVID-19 lead to similar patterns of multiorgan failure. Because SARS-CoV-2 is an infecting organism, it is logical to conclude that severe COVID-19 is indeed sepsis that SARS-CoV-2 causes. In the absence of randomized controlled trials, clinical treatment for COVID-19 patients continues to evolve. Initially, patients presenting with symptoms similar to Acute Respiratory Distress Syndrome were fluid restricted. Moreover, the World Health Organization’s guidance on clinical management of COVID-19, most recently updated in January 2021, specifically recommends considering dynamic assessment to guide fluid administration following initial resuscitation.

Additionally, the pandemic is interrupting the supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Market Segment Analysis

The non-invasive segment is expected to hold the largest market share inpatient fluid status monitor device market.

The non-invasive segment accounted for the largest market share in 2020. The non-invasive device could benefit patients with kidney disease, congestive heart failure, or dehydration. For patients with kidney failure who need dialysis, removing fluid at the correct rate and stopping at the right time is critical, so there is Point-of-care ultrasonography (POCUS) which is emerging as a valuable, non-invasive, bedside diagnostic tool for objective evaluation of physiologic and hemodynamic parameters related to the fluid status, tolerance, and responsiveness. Rapid bedside sonographic evaluation can obtain qualitative data on cardiac function and quantitative data on pulmonary congestion. Moreover, Advanced POCUS, including goal-directed Doppler echocardiography, provides additional quantitative information, including flow velocities and pressures across the cardiac structures. Therefore, the segment is expected to hold the largest market share in the forecast period from the above statements.

Market Geographical Share

North America region holds the largest market share in the global patient fluid status monitor device market

In 2020, North America accounted for the highest revenue share. The increasing prevalence of heart diseases and dehydration among athletes and elderly people, the consumption increase of patient fluid status monitor devices, technological advancement in the medical devices and product launches by the key players are some factors that the market is expected to boost the forecast period. For instance, Heart failure is responsible for 11 million physician visits each year and more hospitalizations than all forms of cancer combined. Moreover, CHF is the first-listed diagnosis in 875,000 hospitalizations and the most common diagnosis in hospital patients age 65 years and older.

Additionally, there is no reliable, easy way to measure hydration levels in these patients, who number around half a million in the United States. However, researchers from MIT and Massachusetts General Hospital have now developed a portable sensor that can accurately measure patients' hydration levels using a technique known as nuclear magnetic resonance (NMR) relaxometry. Such a device could be useful for dialysis patients people with congestive heart failure athletes, and older adults who may be in danger of becoming dehydrated. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Market Key Players and Competitive Landscape

Major key players in the patient fluid status monitor device market are Medtronic, Baxter, ImpediMed, Zynex Medical, Maltron, Serenno Medical, Deltex Medical Limited, and Sensible Medical Innovations LTD.   

Baxter International Inc.:

Overview:

Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company principally focuses on treating hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. Bioscience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine and vaccines. Moreover, the medical products business produces intravenous products and other products used to deliver fluids and drugs to patients; inhalational anesthetics with products, therapies, and digital health solutions are available in more than 100 countries.

Product Portfolio:

Starling Fluid Management System: It offers a fully non-invasive and highly precise approach to fluid management.